Using CRISPR to study gene function aids understanding of 22q11.2 deletion syndrome

Most high-throughput assays to investigate the role of genes in disease involve in vitro cell models. Now a technology that targets CRISPR-Cas9 gene editing to specific cells in mice, and analyses transcriptional effects in single nuclei, has led to fresh insights into the genes involved in 22q11.2 deletion syndrome.